Pfizer Inc. (BVMF:PFIZ34)

Brazil flag Brazil · Delayed Price · Currency is BRL
33.87
+0.08 (0.24%)
Last updated: Aug 27, 2025, 3:39 PM GMT-3
0.24%
Market Cap775.83B
Revenue (ttm)349.70B
Net Income (ttm)58.90B
Shares Outn/a
EPS (ttm)10.38
PE Ratio13.17
Forward PE9.00
Dividend1.65 (4.88%)
Ex-Dividend DateJul 24, 2025
Volume3,941
Average Volume7,582
Open33.80
Previous Close33.79
Day's Range33.78 - 34.20
52-Week Range30.84 - 42.45
Beta0.44
RSI44.09
Earnings DateAug 5, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Sector Healthcare
Founded 1849
Employees 81,000
Stock Exchange Brazil Stock Exchange
Ticker Symbol PFIZ34
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements

News

There is no news available yet.